Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Nov, 1 2025
Nov, 25 2025
Oct, 3 2025
Apr, 26 2025